The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
The compromise, which envisions spending $6.3 billion over the next decade, was condemned by consumer groups and some Democrats as a present to drugmakers that promised only paltry spending increases for underfunded federal programs.
But their objections were overwhelmed by an alliance among Republicans, many Democrats and the White House for a 996-page measure that bore wins for both parties. The Senate’s expected final approval next week would mark an uncommon episode of cooperation between the GOP-run 114th Congress – which plans to adjourn next week – and President Barack Obama in their dwindling days in office.
Click here to Read the full article : House Passes Controversial Medical Funding ‘Cures’ Bill
Share this entry
- Heath Cruise Tolliver, BA, BSN, RN is Appointed to the American Health Council’s Nursing Board April 18, 2018
- The American Health Council Selects Katherine Haymore, MSN, CPNP to Board of Nurses April 17, 2018
- Western New York Children’s Psychiatric Center to Remain in West Seneca April 13, 2018
- Denise Bell, BA, ADN, BSN, MPH is Selected to the American Health Council’s Board of Nurses April 6, 2018
- Dawn Nahrstedt, DNP, APRNC, MSN, BSN, RN is Appointed to the American Health Council’s Board of Nurses April 4, 2018
- AHC Honors Autism Awareness Month April 1, 2018